The FDA was to review the warning about breast and uterine cancer, blood clots, stroke and dementia from menopause therapy.
The 19th News on MSN
The black box warning on menopause treatments could change. Here’s why.
The FDA chief has indicated he’s interested in altering the warning on hormone therapies with estrogen. Experts say it’s ...
The U.S. Food and Drug Administration is reviewing whether to change the warning label on hormone replacement therapy drugs ...
A class of drug that inhibits estrogen production and is used to treat breast cancer has been found to quickly and effectively suppress dangerous brain seizures, according to a new Northwestern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback